747 reports of this reaction
3.9% of all ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR reports
#2 most reported adverse reaction
HEADACHE is the #2 most commonly reported adverse reaction for ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, manufactured by Vertex Pharmaceuticals Incorporated. There are 747 FDA adverse event reports linking ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR to HEADACHE. This represents approximately 3.9% of all 19,269 adverse event reports for this drug.
Patients taking ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 747 FDA reports for ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.9% of all adverse event reports for ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, making it one of the most commonly reported side effect.
If you experience headache while taking ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.